BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26597296)

  • 1. Three-dimensional verification of ¹²⁵I seed stability after permanent implantation in the parotid gland and periparotid region.
    Fan Y; Huang MW; Zheng L; Zhao YJ; Zhang JG
    Radiat Oncol; 2015 Nov; 10():242. PubMed ID: 26597296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive seed migration following parotid gland interstitial brachytherapy.
    Fan Y; Huang MW; Zhao YJ; Gao H; Zhang JG
    Brachytherapy; 2017; 16(6):1219-1224. PubMed ID: 28927732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary results of (125)I interstitial brachytherapy for locally recurrent parotid gland cancer in previously irradiated patients.
    Zheng L; Zhang J; Zhang J; Song T; Huang M; Yu G
    Head Neck; 2012 Oct; 34(10):1445-9. PubMed ID: 22488812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 125I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors.
    Zhang J; Zhang JG; Song TL; Zhen L; Zhang Y; Zhang KH; Yang ZH; Yu GY
    Int J Oral Maxillofac Surg; 2008 Jun; 37(6):515-20. PubMed ID: 18508237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of
    Huang MW; Wu WJ; Lv XM; Yu GY; Zhang JG
    Brachytherapy; 2018; 17(1):244-249. PubMed ID: 29102739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brachytherapy for recurrent malignant tumours of the parotid gland.
    Zhang J; Zheng L; Liu SM; Huang MW; Shi Y; Wang W; Zhang JG
    Br J Oral Maxillofac Surg; 2015 Jan; 53(1):58-62. PubMed ID: 25445387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine-125 brachytherapy alone for advanced primary parotid gland carcinoma.
    Zhou C; Zhang J; Zhang JG; Liu SM; Zheng L; Huang MW; Shi Y; Lv XM
    Int J Oral Maxillofac Surg; 2018 May; 47(5):561-567. PubMed ID: 28966067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mandibular growth in survivors of pediatric parotid gland carcinoma treated with interstitial brachytherapy.
    Wu WJ; Huang MW; Zhang GH; Zhao D; Zheng L; Yu GY; Zhang JG
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27223. PubMed ID: 29797637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [125I seed implant brachytherapy of recurrent parotid gland malignant tumor].
    Zhang J; Zhang JG; Cai ZG; Zhang Y; Huang MX; Yu GY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Jan; 44(1):2-4. PubMed ID: 19489249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (125)I interstitial brachytherapy for the treatment of myoepithelial carcinoma of the oral and maxillofacial region.
    Zheng L; Lv X; Shi Y; Zhang Y; Yu G; Zhang J
    Brachytherapy; 2016; 15(2):240-5. PubMed ID: 26778756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery combined with
    Ma YQ; Zheng L; Huang MW; Liu SM; Lv XM; Zhang JG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Apr; 131(4):395-404. PubMed ID: 33610540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 125I seed implant brachytherapy for the treatment of parotid gland cancers in children and adolescents.
    Zheng L; Zhang J; Song T; Zhang J; Yu G; Zhang Y
    Strahlenther Onkol; 2013 May; 189(5):401-6. PubMed ID: 23519359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Dimensional Printed Plate-Guided
    Liu J; Wu T; Man Q; Fidèle NB; Zheng Y; Liu B
    J Oral Maxillofac Surg; 2018 Oct; 76(10):2113-2121. PubMed ID: 29856941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of radioepidermitis and the dose-response relationship in parotid gland cancer patients treated with 125I seed brachytherapy: incidence of radioepidermitis and the dose-response relationship.
    Mao MH; Zhang JG; Zheng L; Gao H; Zhang J; Liu SM; Huang MW; Shi Y
    Strahlenther Onkol; 2015 Jan; 191(1):26-33. PubMed ID: 25200358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomographic-guided iodine-125 interstitial implants for malignant thoracic tumors.
    Huang Q; Chen J; Chen Q; Lai Q; Cai S; Luo K; Lin Z
    Eur J Radiol; 2013 Nov; 82(11):2061-6. PubMed ID: 23830205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CT-guidance interstitial (125)Iodine seed brachytherapy as a salvage therapy for recurrent spinal primary tumors.
    Cao Q; Wang H; Meng N; Jiang Y; Jiang P; Gao Y; Tian S; Liu C; Yang R; Wang J; Zhang K
    Radiat Oncol; 2014 Dec; 9():301. PubMed ID: 25534142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative fluoroscopic dose assessment in prostate brachytherapy patients.
    Reed DR; Wallner KE; Narayanan S; Sutlief SG; Ford EC; Cho PS
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):301-7. PubMed ID: 16111600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-125 brachytherapy for the treatment of a large parotid epithelial-myoepithelial carcinoma in a child.
    Zhang J; Zhen L; Zhang JG; Yu GY
    Int J Oral Maxillofac Surg; 2014 Dec; 43(12):1431-5. PubMed ID: 25240907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary study of treating parotid gland malignant tumor with saving facial nerve (surgery associated with 125I seed implant brachytherapy)].
    Zhanf JG; Zhang J; Song TL; Zheng L; Cai ZG; Yu GY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Mar; 43(3):132-5. PubMed ID: 18788543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.